MAPT and Alzheimer disease: To compare participants with and without preclinical AD pathology, we stratified the group by high and low levels of NfL and Ng, and divided these groups based on Aβ42 and tau concentrations (the p-tau and t-tau groups merged, since the p-tau group was very small).